A novel selective VPAC2 agonist peptide-conjugated chitosan modified selenium nanoparticles with enhanced anti-type 2 diabetes synergy effectsShaojun Zhao(Xiamen University of Technology), Yi MaInternational Journal of NanomedicineMarch 1, 201710.2147/ijn.s130566Cited by 28SaveCiteExport RISWatch citationsRelated PapersObstructive sleep apnea is associated with greater <scp>MASH</scp> and significant fibrosis severity in patients with obesity: A prospective clinicopathological study|Diabetes Obesity and Metabolism|2026|1